Stakeholders from different industries convened to discuss the roadmap ahead to become the next innovation powerhouse at ...
“If small biotech companies like ours are forced to scale back or shut down, it will not just be a loss for scientific ...
AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...
Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...
Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...
By fusing circular dichroism with high-resolution microspectroscopy and microscopic imaging, this cutting-edge technology is ...
The growth of the cell culture media market is driven by rising demand for biopharmaceuticals, vaccines, and cell-based therapies, fueled by advancements in biotechnology and life sciences research.
Project Vital is a statewide initiative to invest in research, workforce development, and biotech startups, positioning Virginia as a leader in biotechnology. Virginia Tech, Carilion Clinic, and the ...
A joint report by the Institute for Deep Tech Innovation (DEEP) at ESMT Berlin and the Bertelsmann Stiftung highlights Germany’s immense innovation potential in the biotech sector. However, this ...
AbbVie, Danaher, Vertex Pharmaceuticals, Cencora, GSK, Thermo Fisher Scientific, and Moderna are the seven Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks ...
Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results